results

Last reviewed 01/2018

Weight loss was:

  • 6.2% in the orlistat group
  • 4.3% in the placebo group

The orlistat group had favourable changes in the following parameters:

  • HbA1c
  • fasting plasma glucose
  • required dose of oral hypoglycaemc agents